Patents by Inventor Ebrahim Zandi

Ebrahim Zandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110287440
    Abstract: The invention provides a means for reconstituting I?B kinase in yeast in order to study the structure and regulation of IKK and to produce pharmacological therapies to block IKK. This invention can be used to express an IKK complex that is biochemically identical to IKK isolated from native cells and in coupled in vitro kinase assays to screen for its upstream regulators. The IKK expressed by reconstituting the yeast can be used to screen for unknown substrates and for pharmacological therapies that block its activity. The invention could also be used to screen for compounds that enhance its activity. The IKK may also be used as a source of material for crystallization and X-ray diffraction analysis.
    Type: Application
    Filed: August 1, 2011
    Publication date: November 24, 2011
    Inventors: Ebrahim Zandi, Beth Schomer Miller
  • Publication number: 20100055714
    Abstract: The present invention provides an isolated nucleic acid molecules encoding I?B kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (I?B) that inhibits the activity of the NF-?B transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an I?B protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Application
    Filed: October 31, 2007
    Publication date: March 4, 2010
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Patent number: 7314615
    Abstract: The present invention provides an isolated nucleic acid molecules encoding I?B kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (I?B) that inhibits the activity of the NF-?B transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an I?B protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: January 1, 2008
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Publication number: 20070166812
    Abstract: The present invention provides a novel essential regulatory subunit of the I?B kinase (IKK) complex, IKK-?. The isolated IKK-? subunit of the invention has substantially the same amino acid sequence as SEQ ID NO: 2 shown in FIG. 2.
    Type: Application
    Filed: March 9, 2007
    Publication date: July 19, 2007
    Applicant: The Regents of the University of California
    Inventors: Michael Karin, David Rothwarf, Ebrahim Zandi
  • Patent number: 7189832
    Abstract: The present invention provides a novel essential regulatory subunit of the I?B kinase (IKK) complex, IKK-?. The isolated IKK-? subunit of the invention has substantially the same amino acid sequence as SEQ ID NO: 2 shown in FIG. 2.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: March 13, 2007
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, David M. Rothwarf, Ebrahim Zandi
  • Publication number: 20040228849
    Abstract: The present invention provides an isolated nucleic acid molecules encoding IKB kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (I&kgr;B) that inhibits the activity of the NF-&kgr;B transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an I&kgr;B protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Application
    Filed: December 17, 2003
    Publication date: November 18, 2004
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Patent number: 6689575
    Abstract: The present invention provides an isolated nucleic acid molecules encoding I&kgr;B kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (I&kgr;B) that inhibits the activity of the NF-&kgr;B transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an I&kgr;B protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: February 10, 2004
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Publication number: 20030054450
    Abstract: The invention provides a means for reconstituting I&kgr;B kinase in yeast in order to study the structure and regulation of IKK and to produce pharmacological therapies to block IKK. This invention can be used to express an IKK complex that is biochemically identical to IKK isolated from native cells and in coupled in vitro kinase assays to screen for its upstream regulators. The IKK expressed by reconstituting the yeast can be used to screen for unknown substrates and for pharmacological therapies that block its activity. The invention could also be used to screen for compounds that enhance its activity. The IKK may also be used as a source of material for crystallization and X-ray diffraction analysis.
    Type: Application
    Filed: February 19, 2002
    Publication date: March 20, 2003
    Applicant: University of Southern California
    Inventors: Ebrahim Zandi, Beth Schomer Miller
  • Publication number: 20020045235
    Abstract: The present invention provides an isolated nucleic acid molecules encoding I&kgr;B kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (I&kgr;B) that inhibits the activity of the NF-&kgr;B transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an I&kgr;B protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Application
    Filed: February 28, 2001
    Publication date: April 18, 2002
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Patent number: 6268194
    Abstract: The present invention provides a substantially purified nucleic acid molecule encoding a serine protein kinase (I&kgr;B kinase) that phosphorylates a protein (I&kgr;B) that inhibits the activity of the NF-&kgr;B transcription factor, vectors comprising such a nucleic acid molecule and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides a substantially purified I&kgr;B kinase, which is a polypeptide that can phosphorylate an I&kgr;B protein, and peptide portions of the I&kgr;B kinase. In addition, the invention provides anti-I&kgr;B kinase antibodies, which specifically bind to an I&kgr;B kinase, and I&kgr;B kinase-binding fragments of such antibodies.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: July 31, 2001
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi
  • Patent number: 6242253
    Abstract: The present invention provides an isolated nucleic acid molecules encoding IKB kinase (IKK) catalytic subunit polypeptides, which are associated with an IKK serine protein kinase that phosphorylates a protein (IKB) that inhibits the activity of the NF-KB transcription factor, vectors comprising such nucleic acid molecules and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides isolated IKK catalytic subunits, which can phosphorylate an IKB protein, and peptide portions of such IKK subunit. In addition, the invention provides anti-IKK antibodies, which specifically bind to an IKK complex or an IKK catalytic subunit, and IKK-binding fragments of such antibodies.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: June 5, 2001
    Assignee: Regents of the University of California
    Inventors: Michael Karin, Joseph A. DiDonato, David M. Rothwarf, Makio Hayakawa, Ebrahim Zandi